Management of marginal zone lymphomas
M Merli, L Arcaini - Hematology, 2022 - ashpublications.org
Marginal zone lymphomas (MZLs) represent about 7% of B-cell non-Hodgkin lymphomas
and include 3 different subtypes—namely, extranodal (EMZL), nodal, and splenic (SMZL) …
and include 3 different subtypes—namely, extranodal (EMZL), nodal, and splenic (SMZL) …
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma
JP Alderuccio, IS Lossos - Expert review of hematology, 2023 - Taylor & Francis
Introduction Extranodal marginal zone lymphoma (EMZL) of mucosa-associated lymphoid
tissue is an indolent lymphoma originating from marginal zone B-cells and associated with …
tissue is an indolent lymphoma originating from marginal zone B-cells and associated with …
Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma
Background Pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma sometimes
presents as large pulmonary nodules composed of small nodular opacities (galaxy sign) on …
presents as large pulmonary nodules composed of small nodular opacities (galaxy sign) on …
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast
Breast extranodal marginal zone lymphoma (EMZL) is a rare malignancy. We performed the
largest published to date single-center retrospective analysis of 13 patients with breast …
largest published to date single-center retrospective analysis of 13 patients with breast …
Long-term Clinical Outcomes of Optimizing Combination Therapy for Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma: A Retrospective Study
GJ Min, CK Rhee, TY Kim, YW Jeon, O JH… - Acta …, 2023 - karger.com
Introduction: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma progresses
with advancing disease stage. However, no standard treatment approach has been …
with advancing disease stage. However, no standard treatment approach has been …
[HTML][HTML] A Unique Case of Extranodal Marginal Zone Lymphoma with Synchronous Pulmonary and Dermatologic Manifestations.
C Arevalo, F Camacho, J Modrak - Respiratory Medicine Case Reports, 2024 - Elsevier
An 89-year-old male with a medical history of non-ischemic cardiomyopathy was initially
admitted with acute hypoxic respiratory failure attributed to heart failure exacerbation. Aside …
admitted with acute hypoxic respiratory failure attributed to heart failure exacerbation. Aside …
Pulmonary Lymphoma
J Liu, S Zhang - Diagnostic Imaging of Lung Cancers, 2024 - Springer
Lymphoma is a heterogeneous group of malignancies arising from lymph nodes or other
lymphoid tissues and can be classified as Hodgkin's lymphoma (HL)(10%) and non …
lymphoid tissues and can be classified as Hodgkin's lymphoma (HL)(10%) and non …
Long-Term Clinical Outcomes of Optimizing Combination Therapy for Primary Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Study
GJMCK Rheeb, TYKYW Jeonc, JHOBO Choie… - 2023 - karger.com
Introduction: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma progresses
with advancing disease stage. However, no standard treatment approach has been …
with advancing disease stage. However, no standard treatment approach has been …
[HTML][HTML] Kavitha (2022) Extra Nodal Marginal Zone Lymphoma of Lung: A Clinical Report
V Avinash… - J Med Case Rep Case …, 2022 - acquaintpublications.com
Abstract Extra Nodal Marginal Zone lymphoma constitutes 0.4% of lymphomas and 3.6% of
non-Hodgkin's lymphoma. Extra Nodal Marginal Zone lymphoma may occur in many sites …
non-Hodgkin's lymphoma. Extra Nodal Marginal Zone lymphoma may occur in many sites …